1. Home
  2. PHUN vs ANVS Comparison

PHUN vs ANVS Comparison

Compare PHUN & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHUN
  • ANVS
  • Stock Information
  • Founded
  • PHUN 2009
  • ANVS 2008
  • Country
  • PHUN United States
  • ANVS United States
  • Employees
  • PHUN N/A
  • ANVS N/A
  • Industry
  • PHUN EDP Services
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHUN Technology
  • ANVS Health Care
  • Exchange
  • PHUN Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • PHUN 88.8M
  • ANVS 92.6M
  • IPO Year
  • PHUN N/A
  • ANVS 2020
  • Fundamental
  • Price
  • PHUN $3.79
  • ANVS $2.95
  • Analyst Decision
  • PHUN Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • PHUN 3
  • ANVS 6
  • Target Price
  • PHUN $13.00
  • ANVS $29.67
  • AVG Volume (30 Days)
  • PHUN 1.4M
  • ANVS 548.9K
  • Earning Date
  • PHUN 03-11-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • PHUN N/A
  • ANVS N/A
  • EPS Growth
  • PHUN N/A
  • ANVS N/A
  • EPS
  • PHUN N/A
  • ANVS N/A
  • Revenue
  • PHUN $3,537,000.00
  • ANVS N/A
  • Revenue This Year
  • PHUN N/A
  • ANVS N/A
  • Revenue Next Year
  • PHUN $93.33
  • ANVS N/A
  • P/E Ratio
  • PHUN N/A
  • ANVS N/A
  • Revenue Growth
  • PHUN N/A
  • ANVS N/A
  • 52 Week Low
  • PHUN $2.85
  • ANVS $2.88
  • 52 Week High
  • PHUN $19.00
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • PHUN 38.74
  • ANVS 20.82
  • Support Level
  • PHUN $3.71
  • ANVS $2.99
  • Resistance Level
  • PHUN $4.04
  • ANVS $5.50
  • Average True Range (ATR)
  • PHUN 0.27
  • ANVS 0.34
  • MACD
  • PHUN -0.06
  • ANVS -0.18
  • Stochastic Oscillator
  • PHUN 14.28
  • ANVS 3.59

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: